Why it matters:
Group purchasing organizations (GPOs) and wholesalers are alerting pharmacies to historic drops in wholesale acquisition cost (WAC) pricing for certain branded prescription medications. These declines could impact pharmacy reimbursement.

The risk:
Pharmacies that purchased products before the new, lower WACs may face a financial loss due to the gap between the new WAC and their original actual acquisition cost.
Some manufacturers may provide rebates to offset this difference, but eligibility depends on wholesaler contract terms and timing.

What pharmacies should do:
•  Review wholesaler agreements for details on returns and inventory-devaluation policies.
•  Audit current inventory—including stock on shelves and in will-call—to identify affected products and reduce loss exposure.
•  Monitor future pricing: GPOs and wholesalers are warning that additional WAC drops may occur with little notice, so ongoing vigilance is essential.

Learn more:
•  GPO Notice
•  Wholesaler Notice